Henry Schein, Inc. (NASDAQ:HSIC) Shares Acquired by Deroy & Devereaux Private Investment Counsel Inc.

Deroy & Devereaux Private Investment Counsel Inc. grew its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 0.7% in the 3rd quarter, Holdings Channel.com reports. The fund owned 47,055 shares of the company’s stock after buying an additional 325 shares during the period. Deroy & Devereaux Private Investment Counsel Inc.’s holdings in Henry Schein were worth $3,430,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Cromwell Holdings LLC lifted its holdings in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after purchasing an additional 170 shares during the period. Summit Securities Group LLC acquired a new stake in shares of Henry Schein during the second quarter worth about $31,000. Beach Investment Counsel Inc. PA acquired a new stake in shares of Henry Schein during the second quarter worth about $37,000. Blue Trust Inc. lifted its holdings in shares of Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after purchasing an additional 475 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt lifted its holdings in shares of Henry Schein by 282.1% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock worth $109,000 after purchasing an additional 1,100 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently commented on HSIC shares. Barrington Research reaffirmed an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a report on Friday, September 20th. UBS Group decreased their target price on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. Robert W. Baird reduced their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. StockNews.com cut Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday. Finally, JPMorgan Chase & Co. reduced their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $77.50.

Henry Schein Stock Down 0.6 %

Henry Schein stock opened at $70.23 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. Henry Schein, Inc. has a 12 month low of $60.01 and a 12 month high of $82.63. The stock has a market capitalization of $8.90 billion, a PE ratio of 26.01, a price-to-earnings-growth ratio of 2.03 and a beta of 0.86. The business has a 50 day simple moving average of $70.63 and a 200-day simple moving average of $69.78.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, topping the consensus estimate of $1.22 by $0.01. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The firm had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. During the same period in the previous year, the business earned $1.31 earnings per share. The firm’s revenue for the quarter was up .0% on a year-over-year basis. On average, analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Insider Buying and Selling

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.14% of the stock is owned by company insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.